VSAR


Canaccord Slashes Price Target for Versartis Inc to $9.00 as GHD Drug Flunks Phase 3 Trial

Could Versartis recover after today’s big decline?

Ask Analysts: Where Versartis Inc (VSAR), Ascendis Pharma A/S (ASND) Stocks Are Heading from Here?

A ‘game over’ for Versartis’ somavaratan; A powerful boost for Ascendis’ TC-hGH.

Here’s Why Versartis Inc (VSAR) Shares Crashed Today

Friday turned out to be a nightmare for Versartis Inc (NASDAQ:VSAR) investors, after the drug maker reported negative Phase 3 VELOCITY data in …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts